Corrigendum to ‘Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC’ [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]

IF 3.5 Q2 ONCOLOGY

JTO Clinical and Research Reports Pub Date : 2025-01-01 DOI:10.1016/j.jtocrr.2024.100761

Tsuyoshi Hirata MD , Yuji Uehara MD , Taiki Hakozaki MD , Takayuki Kobayashi MD , Yuto Terashima MD , Kageaki Watanabe MD , Makiko Yomota MD, PhD , Yukio Hosomi MD, PhD

引用次数: 0

查看原文本刊更多论文

“简要报告：局部晚期NSCLC患者输注免疫检查点抑制剂的临床结果”的更正[JTO临床和研究报告，第5卷第4期（2024）100659]。

[这更正了文章DOI: 10.1016/j.jtocrr.2024.100659.]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

JTO Clinical and Research Reports Medicine-Oncology

CiteScore

4.20

自引率

0.00%

发文量

145

审稿时长

19 weeks